Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients

Journal of Medical Virology

Volumn 85, Issue 10, 2013, Pages 1802-1810

  Clari, María A ^a   Aguilar, Gerardo ^a   Benet, Isabel ^a   Belda, Javier ^a,b   Giménez, Estela ^a   Bravo, Dayana ^a   Carbonell, José A ^a   Henao, Liliana ^a   Navarro, David ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Active CMV infection; CMV DNA load; Critically ill patients; Cytomegalovirus; T cell immunity

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; GAMMA INTERFERON; HYPERTENSIVE FACTOR; VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGICAL MONITORING; INTENSIVE CARE UNIT; MALE; NONHUMAN; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; TRACHEAL ASPIRATION PROCEDURE; VIRUS LOAD; VIRUS REPLICATION;

ACTIVE CMV INFECTION; CMV DNA LOAD; CRITICALLY ILL PATIENTS; CYTOMEGALOVIRUS; T-CELL IMMUNITY;

AGED; CRITICAL ILLNESS; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DIAGNOSTIC TESTS, ROUTINE; DNA, VIRAL; FEMALE; FLOW CYTOMETRY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PLASMA; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; T-LYMPHOCYTES; TRACHEA; VIRAL LOAD; WOUNDS AND INJURIES;

CYTOMEGALOVIRUS;

EID: 84881028899     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23621     Document Type: Article

References (21)

1. Bone RC. 1996. Sir Isaac Newton sepsis, SIRS, CARS. Crit Care Med 24:1125-1128.
2. Blanquer J, Chilet M, Benet I, Aguilar G, Muñoz-Cobo B, Tellez A, Costa E, Bravo D, Navarro D. 2011. Immunological insights into the pathogenesis of active CMV infection in non-immunosuppressed critically ill patients. J Med Virol 83:1966-1971.
3. Campbell J, Trgovcich J, Kincaid M, Zimmerman PD, Klenerman P, Sims S, Cook CH. 2012. Transient CD8-memory contraction: A potential contributor to latent cytomegalovirus reactivation. J Leukoc Biol 92:933-937.
4. Chiche L, Forel JM, Roch A, Guervilly C, Pauly V, Allardet-Servent J, Gainnier M, Zandotti C, Papazian L. 2009. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 37:1850-1857.
5. Chiche L, Forel JM, Thomas G, Farnarier C, Cognet C, Guervilly C, Zandotti C, Vély F, Roch A, Vivier E, Papazian L. 2012. Interferon-γ production by natural killer cells and cytomegalovirus in critically ill patients. Crit Care Med 40:1-8.
6. Chilet M, Aguilar G, Benet I, Belda J, Tormo N, Carbonell JA, Clari MA, Costa E, Navarro D. 2010. Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. J Med Virol 82:1384-1391.
7. Cook CH. 2007. Cytomegalovirus reactivation, in "immunocompetent", patients A, call for, scientific prophylaxis. J Infect Dis 196:1273-1275.
8. Cohen JI. 2009. Cytomegalovirus in the intensive care unit: Pathogen or passenger? Crit Care Med 37:2095-2096.
9. Escribano A, Chilet M, Clari MA, Lucas R, Costa E, Bravo D, Muñoz-Cobo B, Borrás R, Navarro D. 2013. Frequent detection of cytomegalovirus (CMV) DNA in the lower respiratory tract in CMV-seropositive pediatric patients with underlying chronic bronchopulmonary diseases lacking canonical immunosuppression. J Med Virol 85:888-892.
10. Gimeno C, Solano C, Latorre JC, Hernández-Boluda JC, Clari MA, Remigia MJ, Furió S, Calabuig M, Tormo N, Navarro D. 2008. Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol 46:3311-3318.
11. Griffiths PD. 2010. Cytomegalovirus in intensive care. Rev Med Virol 20:1-3.
12. Kalil AC, Florescu DF. 2009. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppresed patients in the intensive care unit. Crit Care Med 37:2350-2358.
13. Kiecker F, Streitz M, Ay B, Cherepnev G, Volk HD, Volkmer-Engert R, Kern F. 2004. Analysis of antigen-specific T-cell responses with synthetic peptides-what kind of peptide for which purpose? Hum Immunol 65:523-536.
14. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS Intenational Sepsis Definitions Conference. Crit Care Med 31:1250-1256.
15. Limaye AP, Kirby KA, Rubenfels GD, Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, Gibran NS, Huang ML, Santo Hayes TK, Corey L, Boeckh M. 2008. Cytomegalovirus reactivation in critically immunocompetent patients. JAMA 300:413-422.
16. Osawa R, Singh N. 2009. Cytomegalovirus infection in critically ill patients: A systematic review. Crit Care 13:1-10.
17. Papazian L, Fraisse A, Garbe L, Papazian L, Fraisse A, Garbe L, Zandotti C, Thomas P, Saux P, Pierrin G, Gouin F. 1996. Cytomegalovirus: An unexpected cause of ventilator-associated pneumonia. Anesthesiology 84:280-287.
18. + T cells early after allogeneic stem cell transplantation may identify patients at risk of active CMV infection. Haematologica 93:1434-1436.
19. Study of ganciclovir/valganciclovir for prevention of cytomegalovirus reactivation in acute injury of the lung, respiratory failure (GRAIL). ClinicalTrials Gov Identifier NC, T 0133 5932.
20. Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, López J, Garcia-Noblejas A, Muñoz-Cobo B, Costa E, Clari MA, Hernández-Boluda JC, Remigia MJ, Navarro XX. 2011. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT. Bone Marrow Transplant 46: 1437-1443.
21. Von Muller L, Klemm A, Durmus N, Weiss M, Suger-Wiedeck H, Schneider M, Hampl W, Mertens T. 2007. Cellular immunity and active cytomegalovirus infection in patients with septic shock. J Infect Dis 196:1288-1295.